A biomonitoring assessment of secondhand exposures to electronic cigarette emissions.
Biological monitoring
Cotinine
Electronic cigarettes
Nicotine
Secondhand exposures
Journal
International journal of hygiene and environmental health
ISSN: 1618-131X
Titre abrégé: Int J Hyg Environ Health
Pays: Germany
ID NLM: 100898843
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
received:
15
02
2019
accepted:
26
04
2019
pubmed:
16
5
2019
medline:
1
4
2020
entrez:
16
5
2019
Statut:
ppublish
Résumé
Electronic cigarette (e-cigarette) conventions regularly bring together thousands of users around the world. In these environments, secondhand exposures to high concentrations of e-cigarette emissions are prevalent. Some biomarkers for tobacco smoke exposure may be used to characterize secondhand e-cigarette exposures in such an environment. Participants who did not use any tobacco product attended four separate e-cigarette events for approximately six hours. Urine and saliva samples were collected from participants prior to the event, immediately after the event, 4-h after the event, and the next morning (first void). Urine samples from 34 participants were analyzed for cotinine, trans-3'-hydroxycotinine, S-(3-hydroxypropyl)-N-acetylcysteine (3-HPMA), S-carboxyethyl-N-acetylcysteine (CEMA), select tobacco-specific nitrosamines (TSNAs), and 8-isoprostane. Saliva samples were analyzed for cotinine and trans-3'-hydroxycotinine. Data from 28 of 34 participants were used in the data analysis. Creatinine-adjusted urinary cotinine concentrations increased up to 13-fold and peaked 4-h after completed exposure (range of adjusted geometric means [AGMs] = 0.352-2.31 μg/g creatinine). Salivary cotinine concentrations were also the highest 4-h after completed exposure (range of AGMs = 0.0373-0.167 ng/mL). Salivary cotinine and creatinine-corrected concentrations of urinary cotinine, trans-3'-hydroxycotinine, CEMA, and 3-HPMA varied significantly across sampling times. Urinary and salivary cotinine, urinary trans-3'-hydroxycotinine, and urinary 3-HPMA concentrations also varied significantly across events. Secondhand e-cigarette exposures lasting six hours resulted in significant changes in exposure biomarker concentrations of both nicotine and acrolein but did not change exposure to tobacco-specific nitrosamines. Additional research is needed to understand the relationship between biomarker concentrations and environmental concentrations of toxicants in e-cigarette emissions.
Sections du résumé
BACKGROUND
Electronic cigarette (e-cigarette) conventions regularly bring together thousands of users around the world. In these environments, secondhand exposures to high concentrations of e-cigarette emissions are prevalent. Some biomarkers for tobacco smoke exposure may be used to characterize secondhand e-cigarette exposures in such an environment.
METHODS
Participants who did not use any tobacco product attended four separate e-cigarette events for approximately six hours. Urine and saliva samples were collected from participants prior to the event, immediately after the event, 4-h after the event, and the next morning (first void). Urine samples from 34 participants were analyzed for cotinine, trans-3'-hydroxycotinine, S-(3-hydroxypropyl)-N-acetylcysteine (3-HPMA), S-carboxyethyl-N-acetylcysteine (CEMA), select tobacco-specific nitrosamines (TSNAs), and 8-isoprostane. Saliva samples were analyzed for cotinine and trans-3'-hydroxycotinine.
RESULTS
Data from 28 of 34 participants were used in the data analysis. Creatinine-adjusted urinary cotinine concentrations increased up to 13-fold and peaked 4-h after completed exposure (range of adjusted geometric means [AGMs] = 0.352-2.31 μg/g creatinine). Salivary cotinine concentrations were also the highest 4-h after completed exposure (range of AGMs = 0.0373-0.167 ng/mL). Salivary cotinine and creatinine-corrected concentrations of urinary cotinine, trans-3'-hydroxycotinine, CEMA, and 3-HPMA varied significantly across sampling times. Urinary and salivary cotinine, urinary trans-3'-hydroxycotinine, and urinary 3-HPMA concentrations also varied significantly across events.
CONCLUSION
Secondhand e-cigarette exposures lasting six hours resulted in significant changes in exposure biomarker concentrations of both nicotine and acrolein but did not change exposure to tobacco-specific nitrosamines. Additional research is needed to understand the relationship between biomarker concentrations and environmental concentrations of toxicants in e-cigarette emissions.
Identifiants
pubmed: 31085112
pii: S1438-4639(19)30149-X
doi: 10.1016/j.ijheh.2019.04.013
pmc: PMC6938228
mid: NIHMS1048023
pii:
doi:
Substances chimiques
Biomarkers
0
Tobacco Smoke Pollution
0
hydroxycotinine
27323-64-4
Acrolein
7864XYD3JJ
Cotinine
K5161X06LL
Acetylcysteine
WYQ7N0BPYC
Types de publication
Journal Article
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
816-823Subventions
Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States
Organisme : NIOSH CDC HHS
ID : T42 OH008436
Pays : United States
Informations de copyright
Published by Elsevier GmbH.
Références
Biomed Chromatogr. 2014 Mar;28(3):375-84
pubmed: 24127240
Tob Control. 2013 May;22(3):164-71
pubmed: 22940677
Prog Lipid Res. 1997 Mar;36(1):1-21
pubmed: 9373618
Curr Med Chem. 2007;14(6):703-17
pubmed: 17346157
Anal Sci. 2013;29(12):1219-22
pubmed: 24334991
J Anal Toxicol. 2005 Nov-Dec;29(8):814-8
pubmed: 16374940
Occup Environ Med. 2001 Oct;58(10):649-55
pubmed: 11555686
Int J Occup Med Environ Health. 2016;29(2):179-90
pubmed: 26670350
Indoor Air. 2013 Feb;23(1):25-31
pubmed: 22672560
MMWR Morb Mortal Wkly Rep. 2014 Dec 12;63(49):1145-50
pubmed: 25503916
Environ Sci Technol. 2016 Sep 6;50(17):9644-51
pubmed: 27461870
Chest. 2012 Jun;141(6):1400-1406
pubmed: 22194587
J Anal Toxicol. 2000 Jul-Aug;24(5):333-9
pubmed: 10926356
J Community Health. 2018 Feb;43(1):164-174
pubmed: 28681280
Tob Control. 2014 Mar;23(2):133-9
pubmed: 23467656
Environ Health Perspect. 2012 Jul;120(7):1010-6
pubmed: 22484462
Am J Physiol Lung Cell Mol Physiol. 2017 Sep 1;313(3):L425-L452
pubmed: 28522563
Int J Hyg Environ Health. 2018 Apr;221(3):541-547
pubmed: 29477829
Environ Health Perspect. 2015 Dec;123(12):1302-8
pubmed: 26024353
Free Radic Biol Med. 2005 Mar 15;38(6):698-710
pubmed: 15721980
Environ Health Perspect. 1999 May;107 Suppl 2:349-55
pubmed: 10350520
PLoS One. 2017 Jan 11;12(1):e0169811
pubmed: 28076380
J Public Health Policy. 2015 Nov;36(4):440-51
pubmed: 26424201
Int J Hyg Environ Health. 2014 Jul;217(6):628-37
pubmed: 24373737
Nicotine Tob Res. 2017 Sep 01;19(9):1055-1061
pubmed: 28340080
Pharmacol Rev. 2005 Mar;57(1):79-115
pubmed: 15734728
Anal Chim Acta. 2012 Oct 31;750:152-60
pubmed: 23062436
Environ Res. 2014 Nov;135:76-80
pubmed: 25262078